The Committee on Health, Education, Labor, and Pensions, chaired by Senator Bernie Sanders (I‑VT), held a recent hearing in which he asked the CEO of Novo Nordisk why its diabetes and weight loss drugs, Ozempic and Wegovy, cost much less in Europe than in the United States.